RecallRadar

FDA Device recall Z-1024-2022

ADVIA Centaur Enhanced Estradiol (eE2) 500T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10491445 All lots

On 2022-05-11 the FDA classified a Class II recall of ADVIA Centaur Enhanced Estradiol (eE2) 500T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10491445 All lots by Siemens Healthcare Diagnostics, citing falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1024-2022
ClassificationClass II
Statusongoing
Initiated2022-03-03
Published2022-05-11
Last updated2026-09-13 11:56 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

ADVIA Centaur Enhanced Estradiol (eE2) 500T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10491445 All lots

Reason

Falsely Elevated Results Observed with Plasma Specimens, could lead a clinician to misinterpret patient results

Identifiers

code_info
All lot numbers UDI: (01)00630414574646(10)14530079(17)20220304 (01)00630414574646(10)53553079(17)20220304 (01)00630414…All lot numbers UDI: (01)00630414574646(10)14530079(17)20220304 (01)00630414574646(10)53553079(17)20220304 (01)00630414574646(10)54118081(17)20220521 (01)00630414574646(10)62860081(17)20220521 (01)00630414574646(10)70552083(17)20220805 (01)00630414574646(10)76807076(17)20220115 (01)00630414574646(10)93281076(17)20220115

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1024-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.